- About Us
-
Our Business
-
- Therapeutic Areas Our portfolio is diverse and based upon - Market Research, Regulatory & IP.
- Licensing Licensing activities are excellent opportunities for companies to expand their portfolio.
- Biosimilar Biosimilar are biologic medicines that are developed to match their reference medicine.
-
- CRAM India has grown to be one of the key nations complying GMP manufacturing norms.
- Medical Devices REVA help our clients to deliver customized, cost-effective medical device value chain.
-
API
-
Dosage form
-
-
Operations
- At Reva, we have requisite infrastructure, with a balanced reach across Regulated, Emerging & Expansion markets. And we are committed to helping create healthier communities worldwide through education, outreach and better access to treatment.
-
Research & Development
-
Manufacturing
-
Quality
- Media
- Contact us
Latest News
Nearly a year after COVID vaccines became freely available in the U.S., one fourth of American adults remain...
Read More
Read More
Mylab to open new manufacturing facility in Visakhapatnam for Advanced Diagnostics
The new facility to...
Read More
The new facility to...
Read More
Rhode Island reaches $107 mln opioid settlements with Teva and Allergan
Rhode Island's attorney general on...
Read More
Rhode Island's attorney general on...
Read More
Surge in audit inspections could be periodic or could also be linked to evolving standards in manufacturing
...
Read More
...
Read More
Pfizer said on Wednesday it has begun a mid-to-late-stage study of its antiviral COVID-19 pill for non-hospitalized...
Read More
Read More
Moderna Inc (MRNA.O) said on Monday, March 7 it plans to develop and begin testing vaccines targeting 15 of the world's...
Read More
Read More
Covid-19 treatment update also streamlines use of Regeneron-Roche’s monoclonal antibody cocktail
Even as...
Read More
Even as...
Read More
Indian drug-makers can look for significant gains in pharma exports to the United Arab Emirates, thanks to the new trade...
Read More
Read More
Found to be effective in preventing disease progression and hospitalisation
Molnupiravir, an antiviral drug...
Read More
Molnupiravir, an antiviral drug...
Read More
We are now seeing cases of a sub-variant of Omicron, known as BA.2, emerge in Australia and more than 50 countries....
Read More
Read More
U.S. regulators are considering the first COVID-19 vaccine for children under the age of 5, the only age group not yet...
Read More
Read More
The BA.2 subvariant of the Omicron coronavirus variant, which has quickly taken over in Denmark, is more transmissible...
Read More
Read More